Everything you need to make the right decisions
Providing the most comprehensive and up-to-date information and analysis of the Gastrointestinal Remedies market, its consumers and the major players who make up that market.
Mintel has the answers you’re looking for
- What are the key challenges facing the industry?
- Who is the consumer and what do they want?
- Where are the opportunities, where are the risks and what lies ahead?
Point of sale market data
In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money onMarket Size
How big is the market today and what is our 5 year forecast? Includes both best & worst case scenariosMarket Segmentation
What are the different segments within the market and how are those individual segments performing?
What are consumers looking for, what drives their buying habits and what are their main purchase influencers?Demographic breakdown
From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?Representative sample
We gather our data from real-world consumers, selected to accurately reflect precise global demographics
What are the key players doing, what has been successful for them and what was their marketing spend?Product innovation
Using data from our Global New Product Database, what products were launched and how well were they perceived?Opportunities
What happens next, which areas are likely to experience growth and what opportunities exist within the market?
Covered in this report
This report analyses the market for all types of indigestion and
stomach remedies available over the counter, which together
constitute the GI remedies market.
The five main categories are as follows:
Indigestion/heartburn remedies range from simple antacids
such as Rennie or wind relief such as Setlers or Wind-eze to
more potent medication such as Gaviscon or Zantac.
Laxatives relieve constipation and work in one of several ways,
either by introducing fibre to the bowel, stimulating the bowel or
Anti-diarrhoeals are usually opiate-based to slow down the
movement of waste through the bowel, and/or contain kaolin to
add bulk to waste and neutralise bacteria. This segment also
includes rehydrating solutions, or electrolyte solutions, which
replace the fluid and salts lost when suffering from diarrhoea.
Stomach upset remedies, for example, Alka-Seltzer or Andrews,
relieve nausea and settle the stomach.
IBS products provide symptomatic relief for the spasms and
bloating which are typical of IBS. Many of these products, such
as Colpermin, are based on peppermint oil, which is naturally
soothing for gastrointestinal problems.
This report covers only OTC (over-the-counter) (non-prescription)
medication, defined by the Proprietary Association of Great Britain
“Specifically designed to treat the symptoms of common, minor
and self-limiting ailments that do not require a medical diagnosis.”
They are divided into two categories:
P: Pharmacy-only products, which can only be sold through
pharmacies by, or in the presence of, a qualified pharmacist.
GSL: General Sales List, which can be sold in any type of outlet.
Prescription-only Medicines (POMs), which have to be prescribed
by a GP (General Practitioner) and dispensed by a qualified
pharmacist, are not included within the scope of this Report.
What you need to know
The GI (gastrointestinal) remedies market is forecast to continue
on its growth trajectory in 2018, with value sales rising to an
expected £308 million from £300 million in 2017.
Although the market is broadly a mature one, marked by low
levels of true NPD (New Product Development), pockets of
faster growth remain. For example, remedies for IBS (irritable
bowel syndrome) represent a growth area, as more people are
diagnosed – or indeed self-diagnose – with the condition, whilst
rising levels of stress are expected to drive GI complaints and
subsequently sales of products to help ease symptoms.
Expert analysis from a specialist in the field
Written by Hera Crossan, a leading analyst in the Health & Wellness sector, her extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.
In a mature market, finding growth can be a challenge. Gastrointestinal remedies has faced this issue, but brands have benefited from an increase in consumers seeking to alleviate GI symptoms arising from stress, IBS and shifts in dietary habits. With these issues likely to continue, the market is set to see continued investment from those who appear to prefer the convenience of addressing symptoms over tackling root causes.Hera Crossan
Health & Wellness Analyst